cetyltrimethylammonium ion has been researched along with Cystic Fibrosis in 3 studies
Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pseudomonas Isolation Agar (selective agent, Irgasan, 25 mg/1) and Pseudomonas Selective Agar (selective agents, cetrimide 200mg/1 and nalidixic acid 15 mg/1) inhibited some strains of P aeruginosa from cystic fibrosis sputum but did not inhibit isolates from other sources." | 3.67 | Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. ( Fonseca, K; MacDougall, J; Pitt, TL, 1986) |
| "The vaccines each contained influenza A/Bangkok/79, A/Brazil/78, B/Singapore/79; two doses were given one month apart." | 1.27 | Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines. ( Bernius, M; Denning, CR; Gaerlan, PF; Gross, PA; Lazicki, M; Quinnan, GV, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcinkowski, AL | 1 |
| Garoff, S | 1 |
| Tilton, RD | 1 |
| Pilewski, JM | 1 |
| Corcoran, TE | 1 |
| Gross, PA | 1 |
| Quinnan, GV | 1 |
| Gaerlan, PF | 1 |
| Denning, CR | 1 |
| Lazicki, M | 1 |
| Bernius, M | 1 |
| Fonseca, K | 1 |
| MacDougall, J | 1 |
| Pitt, TL | 1 |
3 other studies available for cetyltrimethylammonium ion and Cystic Fibrosis
| Article | Year |
|---|---|
Postdeposition dispersion of aerosol medications using surfactant carriers.
Topics: Aerosols; Animals; Biological Products; Cells, Cultured; Cetrimonium; Cetrimonium Compounds; Cystic | 2008 |
Influenza vaccines in children. Comparison of new cetrimonium bromide and standard ether-treated vaccines.
Topics: Adult; Cetrimonium; Cetrimonium Compounds; Child; Cystic Fibrosis; Humans; Influenza Vaccines; Influ | 1983 |
Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media.
Topics: Carbanilides; Cetrimonium; Cetrimonium Compounds; Culture Media; Cystic Fibrosis; Humans; Nalidixic | 1986 |